 |
 |

Measuring Visual Function and Quality of Life in Patients With Cytomegalovirus RetinitisDevelopment of a Questionnaire
Albert W. Wu, MD, MPH;
Laura C. Coleson, RN, MPH;
Janet Holbrook, MS, MPH;
Douglas A. Jabs, MD;
Studies of Ocular Complication of AIDS Research Group
Arch Ophthalmol. 1996;114(7):841-847.
Abstract
 |  |
Objective To develop and test a brief questionnaire designed to assess visual symptoms, visual function in daily activities, and impact of treatment administration in patients with cytomegalovirus retinitis related to acquired immunodeficiency syndrome.
Design Observational cross-sectional study. Patients were recruited in June and July 1992.
Setting Seven university-based sites participating in the Studies of Ocular Complications of AIDS.
Patients Twenty-six subjects enrolled in a randomized trial that compared foscarnet and ganciclovir for the treatment of cytomegalovirus retinitis.
Main Outcome Measures and Analysis Distributions of scores, reliability, and validity of newly developed scales to assess visual function, visual symptoms, and global vision. Spearman rank correlations with 95% confidence intervals were used to test hypothesized relationships between scale scores, visual acuity, visual field, and findings from visual examination.
Results The final 18-item self-administered questionnaire required 5 minutes to complete. The new scales had high internal consistency (Cronbach =.81 to.94). As hypothesized, patient-reported vision scores decreased with greater abnormalities found on ophthalmologic examination. Visual symptoms were most strongly related to findings in the worse eye. Visual function and global vision scores were moderately correlated with findings from visual testing and examination, and less strongly related to general health perceptions. Patients reported considerable impairment: 42% reported blurred vision; 40%, difficulty reading; 44%, difficulty driving; and 40%, that treatment interfered with social activities; 50% reported substantial trouble with their vision.
Conclusions The brief questionnaire developed to assess patient-reported visual function in cytomegalovirus retinitis appears reliable and valid as a measure of performance of vision-related activities, visual symptoms, and the impact of treatment administration. Further research is needed to test its utility as an outcome measure in longitudinal studies of cytomegalovirus retinitis.
Author Affiliations
From the Departments of Health Policy and Management (Dr Wu) and Epidemiology (Ms Holbrook), School of Hygiene and Public Health, and the Departments of Medicine (Drs Wu and Jabs) and Ophthalmology (Ms Coleson and Dr Jabs), School of Medicine, The Johns Hopkins University, Baltimore, Md. Members of the Studies of Ocular Complication of AIDS Research Group are listed in a box on page 846.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Evaluation of the Relationship Between Ablation Diameter, Pupil Size, and Visual Function With Vision-Specific Quality-of-Life Measures After Laser In Situ Keratomileusis
Schmidt et al.
Arch Ophthalmol 2007;125:1037-1042.
ABSTRACT
| FULL TEXT
The VF-14 and Psychological Impact of Amblyopia and Strabismus.
Sabri et al.
IOVS 2006;47:4386-4392.
ABSTRACT
| FULL TEXT
The Development of the LV Prasad-Functional Vision Questionnaire: A Measure of Functional Vision Performance of Visually Impaired Children
Gothwal et al.
IOVS 2003;44:4131-4139.
ABSTRACT
| FULL TEXT
Correlation between visual function and visual ability in patients with uveitis
Gardiner et al.
Br J Ophthalmol 2002;86:993-996.
ABSTRACT
| FULL TEXT
Visual Function and Subjective Quality of Life Compared in Subjects with Acquired Macular Disease
Hazel et al.
IOVS 2000;41:1309-1315.
ABSTRACT
| FULL TEXT
Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?
McClure et al.
Br J Ophthalmol 2000;84:244-250.
ABSTRACT
| FULL TEXT
A vision specific functional index for use in patients with age related macular degeneration
Hart et al.
Br J Ophthalmol 1999;83:1115-1120.
ABSTRACT
| FULL TEXT
Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL
Terwee et al.
Br J Ophthalmol 1998;82:773-779.
ABSTRACT
| FULL TEXT
MSL-109 Adjuvant Therapy for Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome: The Monoclonal Antibody Cytomegalovirus Retinitis Trial
The Studies of Ocular Complications of AIDS Resear
Arch Ophthalmol 1997;115:1528-1536.
ABSTRACT
Unperceived Visual Field Defects
Safran
Arch Ophthalmol 1997;115:686-687.
ABSTRACT
Use of Quality-of-Life Instruments in Randomized Clinical Trials
Sommer
Arch Ophthalmol 1997;115:564-565.
ABSTRACT
Acquired Immunodeficiency Syndrome and the Eye--1996
Jabs
Arch Ophthalmol 1996;114:863-866.
ABSTRACT
|